Gilbert & Cook, Inc. Abb Vie Inc. Transaction History

Gilbert & Cook, Inc.

$718 Million
Q3 2024

A detailed history of Gilbert & Cook, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Gilbert & Cook, Inc. holds 9,193 shares of ABBV stock, worth $1.67 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

9,193

Previous 8,061 14.04%

Holding current value

$1.67 Million

Previous $1.38 Million 31.33%

% of portfolio

0.25%

Previous 0.2%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$163.84 - $199.33 $185,466 - $225,641	1,132 Added 14.04%	9,193 $1.82 Million
Q2 2024 Aug 01, 2024	SELL	$154.79 - $180.76 $94,267 - $110,082	-609 Reduced 7.02%	8,061 $1.38 Million
Q1 2024 May 02, 2024	SELL	$159.82 - $182.1 $163,176 - $185,924	-1,021 Reduced 10.54%	8,670 $1.58 Million
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $118,473 - $133,429	861 Added 9.75%	9,691 $1.5 Million
Q3 2023 Nov 02, 2023	BUY	$133.59 - $154.65 $60,382 - $69,901	452 Added 5.4%	8,830 $1.32 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $42,138 - $52,438	318 Added 3.95%	8,378 $1.13 Million
Q1 2023 May 05, 2023	BUY	$144.61 - $166.54 $9,399 - $10,825	65 Added 0.81%	8,060 $1.28 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $14,245 - $17,084	-103 Reduced 1.27%	7,995 $1.29 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $18,252 - $20,934	136 Added 1.71%	8,098 $1.17 Million
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $63,580 - $80,831	462 Added 6.16%	7,962 $1.22 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $23,624 - $29,311	179 Added 2.45%	7,500 $1.22 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $247,411 - $313,046	2,303 Added 45.89%	7,321 $991,000
Q3 2021 Jan 20, 2022	BUY	$106.4 - $120.78 $409,001 - $464,278	3,844 Added 327.43%	5,018 $541,000
Q3 2021 Oct 13, 2021	SELL	$106.4 - $120.78 $390,381 - $443,141	-3,669 Reduced 75.76%	1,174 $541,000
Q2 2021 Jul 13, 2021	BUY	$105.21 - $117.21 $10,100 - $11,252	96 Added 2.02%	4,843 $546,000
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $50,843 - $55,972	497 Added 11.69%	4,747 $514,000
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $372,427 - $502,816	-4,627 Reduced 52.12%	4,250 $457,000
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $37,284 - $43,760	434 Added 5.14%	8,877 $778,000
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $125,976 - $168,575	1,717 Added 25.53%	8,443 $829,000
Q1 2020 May 05, 2020	BUY	$64.5 - $97.79 $60,307 - $91,433	935 Added 16.15%	6,726 $512,000
Q4 2019 Feb 03, 2020	BUY	$72.13 - $90.25 $220,285 - $275,623	3,054 Added 111.58%	5,791 $513,000
Q3 2019 Nov 05, 2019	BUY	$62.98 - $75.72 $172,376 - $207,245	2,737 New	2,737 $207,000
Q1 2018 Apr 30, 2018	SELL	$92.01 - $123.21 $210,702 - $282,150	-2,290 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$89.56 - $98.21 $205,092 - $224,900	2,290	2,290 $221,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilbert & Cook, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gilbert & Cook, Inc. with notifications on news.

Account